Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients

BACKGROUND: By the use of PSMA positron emission tomography (PET) detection of prostate cancer lesions with a high sensitivity and specificity combined with a favorable lesion to background contrast is feasible. Therefore, PSMA-PET is increasingly used for planning of radiotherapy treatment; however...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschaeck, Sebastian, Wust, Peter, Beck, Marcus, Wlodarczyk, Waldemar, Kaul, David, Rogasch, Julian, Budach, Volker, Furth, Christian, Ghadjar, Pirus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568206/
https://www.ncbi.nlm.nih.gov/pubmed/28830532
http://dx.doi.org/10.1186/s13014-017-0877-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568206/
https://www.ncbi.nlm.nih.gov/pubmed/28830532
http://dx.doi.org/10.1186/s13014-017-0877-x

Ejemplares similares